SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)
BCRX 7.160+5.8%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (179)9/20/2007 6:20:43 PM
From: Archie Meeties  Read Replies (2) of 269
 
Your take is that the CK explanation was the result of a post hoc analysis?

I don't think blinding should have included blinding of CK results as that is a measure of methods, not results. If CK data was blinded then somebody botched the design. If it wasn't then even a casual look at the data should have suggested something was wrong with drug delivery.

There no magic in the whole im/ck stuff...you traumatize muscle when you inject into it and so ck leaks out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News